On this page
📌 FDA & Cosmetics Safety Hub: browse all 7 guides »
A cosmetic ingredient list can help you identify a listed PFAS ingredient. It cannot, by itself, establish that a product contains no PFAS, determine your exposure or settle whether that product is safe. For a U.S. consumer, the useful next step is to record exactly what the label says, then ask the manufacturer questions that address what remains unknown.
This guide draws on FDA webpages captured on October 23, 2026: the PFAS page at 18:34:54 UTC and the MoCRA page at 18:34:55 UTC. It is a source-based reading method, not a product investigation.
What the FDA information contributes
FDA’s PFAS cosmetics page names polytetrafluoroethylene (PTFE) among PFAS ingredients. It distinguishes intentional use from possible unintended presence through impurities or ingredient breakdown. Its description of FDA’s assessment identifies gaps in use-level, absorption, mechanistic and dermal-toxicity information. This article relies on that webpage’s account; the underlying scientific report has not been reviewed.
The practical distinction is between a label observation and a chemical conclusion. Finding a named ingredient supports a statement about what is declared. Not finding that name supports only a statement about your search—not a comprehensive finding of absence. The same limit applies to a position on the list: see U.S. Cosmetic Ingredient Order: Why Position Is Not an Exact Percentage. Do not turn FDA’s examples into a complete screening list or assume that recognizing part of a chemical name establishes its classification.
A proposed PFAS reading worksheet
Use one record for one identified product and label version. Keep observations separate from interpretations, and leave unanswered fields visibly unresolved. The blank row below is reusable; the filled row is entirely hypothetical and does not describe an evaluated product.
| Exact label wording | FDA webpage context | Permissible interpretation | Manufacturer question | Unresolved information |
|---|---|---|---|---|
| Blank: copy wording here | Record the relevant FDA statement and capture date. | Write only what this observation supports. | Ask about the particular missing information. | Mark unknowns; attach any dated reply. |
| Hypothetical: polytetrafluoroethylene (PTFE) | FDA names PTFE as a PFAS ingredient. | This hypothetical label declares a named PFAS ingredient; this is not independent chemical verification. | Does this ingredient list apply to the identified product and formula version? What information supports your answer about PFAS? | Actual composition, concentration, exposure and product-specific safety are not established by this row. |
Alongside the worksheet, record the product name, variant, any batch identifier, where you obtained the ingredient wording and when you recorded it. These are proposed recordkeeping fields, not evidence that the product has been tested. If packaging and an online list differ, preserve both versions rather than silently combining them.
Choose the next question from your finding
- You recognize a listed PFAS example: ask the manufacturer to confirm that the list applies to your product version. Keep ingredient identification separate from any conclusion about harm.
- You find no match: record which names you checked. Ask separately about intentional ingredients and possible unintended presence. Do not replace a limited search result with an absence guarantee.
- You encounter a PFAS-related marketing claim: ask what definition and product scope the company uses, and whether the statement concerns formulation records, testing or something else.
- The reply mentions testing: request the report date, material tested, substances covered and reporting limits. These questions help clarify the evidence’s scope; they do not make the worksheet a safety assessment.
Where MoCRA fits—and where it does not
The captured FDA MoCRA overview provides regulatory context. It defines the responsible person as the manufacturer, packer or distributor named on the label. That gives you a concrete label-based starting point for an inquiry, rather than guessing which company to contact.
Keep that regulatory context in a different column from product evidence. Neither the overview nor the PFAS webpage supplies a measurement for the cosmetic in your hand. A bounded FDA test result has the same limit — a historical sample finding does not certify the product in your hand: see FDA’s 2023 Talc Testing: What “Asbestos Not Detected” Means for Your Cosmetic. Likewise, a company’s general reassurance should not be entered as a measured result unless supporting evidence actually provides one.
The worksheet and the questions are two different tools
The article gives the reader two tools that look alike but do different jobs. The worksheet records what the label says: the exact wording, the FDA webpage context, what the observation supports, what to ask the manufacturer, and what stays unresolved. The next-question section does the opposite work: it takes a finding and turns it into a question. A recognized PFAS example means asking the manufacturer to confirm that the list applies to your product version. No match means recording which names you checked, and asking separately about intentional ingredients and possible unintended presence. A marketing claim means asking what definition and product scope the company uses. A mention of testing means asking for the report date, the material tested, the substances covered, and the reporting limits. The worksheet is for writing down; the questions are for writing out. Neither one decides whether a product is safe, and the article says so in both places.
Two columns, one rule
The article keeps two kinds of information in separate columns throughout: what the FDA pages say, and what the product in your hand shows. The MoCRA section follows the same rule. The MoCRA overview tells you who the responsible person is — the manufacturer, packer, or distributor named on the label — which gives you someone concrete to contact instead of guessing which company to ask. It does not tell you anything about the cosmetic itself. The rule holds in both directions: a company’s general reassurance should not be entered as a measured result unless supporting evidence actually provides one, and a bounded test result from the past does not certify the product in your hand. That is why the worksheet’s last column exists. “Unresolved information” is not a failure of the method; it is the method working as designed, leaving the question open until better evidence arrives.
Finish with an honest stopping point
A useful completed record may still end with unknowns. Save the manufacturer’s exact response and date, distinguish it from your interpretation, and note questions it did not answer. No response is an unresolved inquiry—not proof of presence or absence.
This worksheet does not rank products, recommend treatment or establish individual safety. Revisit it if the label, formula, manufacturer’s evidence or relevant FDA guidance changes. Its purpose is narrower: to make your next question more precise without making your conclusion stronger than the evidence.
